1. Corporate Officers - S
2. Scibetta James S

Insider Trading History of Scibetta James S

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Scibetta James S since 2011. The trader's CIK number is 1383242. At the time of the last reporting, Scibetta James S was the Chief Financial Officer of Aquestive Therapeutics, Inc.. (stock ticker symbol AQST). Also see all insider trading activities at Aquestive Therapeutics, Inc..

Note that in the past Scibetta James S also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Matinas Biopharma Holdings, Inc. (MTNB) by Scibetta James S

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2017	MTNB	5,000	$6,450	0	$0	0	$0

Yearly summary of insider trading at Pacira Biosciences, Inc. (PCRX) by Scibetta James S

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2017	PCRX	0	$0	41,966	$1,882,769	40,000	$180,800
2016	PCRX	0	$0	45,000	$1,860,250	45,000	$72,450
2015	PCRX	5,000	$306,850	15,000	$1,673,130	15,000	$24,150
2014	PCRX	0	$0	55,000	$4,496,960	55,000	$88,550
2013	PCRX	0	$0	30,000	$1,032,760	30,000	$48,300
2011	PCRX	5,000	$35,200	0	$0	0	$0

Yearly summary of insider trading at Aquestive Therapeutics, Inc. (AQST) by Scibetta James S

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2019	AQST	22,971	$86,976	0	$0	0	$0

Insider trading activities at 3 companies by Scibetta James S:

1. Matinas Biopharma Holdings, Inc. (MTNB)

2. Pacira Biosciences, Inc. (PCRX)

3. Aquestive Therapeutics, Inc. (AQST)

Table 1. Insider trading of Matinas Biopharma Holdings, Inc. (MTNB) by Scibetta James S

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2017-09-07	MTNB	Buy	5,000	1.29	6,450

Table 2. Insider trading of Pacira Biosciences, Inc. (PCRX) by Scibetta James S

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2017-06-05	PCRX	Sale	1,966	43.32	85,169
2017-05-15	PCRX	Option Ex	20,000	5.49	109,800
2017-05-15	PCRX	Sale	20,000	51.20	1,024,000
2017-01-17	PCRX	Sale	20,000	38.68	773,600
2017-01-17	PCRX	Option Ex	20,000	3.55	71,000
2016-11-15	PCRX	Option Ex	20,000	1.61	32,200
2016-11-15	PCRX	Sale	20,000	36.50	730,000
2016-08-15	PCRX	Option Ex	25,000	1.61	40,250
2016-08-15	PCRX	Sale	25,000	45.21	1,130,250
2015-09-11	PCRX	Buy	5,000	61.37	306,850
2015-02-06	PCRX	Option Ex	15,000	1.61	24,150
2015-02-06	PCRX	Sale	15,000	111.54	1,673,130
2014-11-07	PCRX	Option Ex	15,000	1.61	24,150
2014-11-07	PCRX	Sale	15,000	88.13	1,321,980
2014-08-08	PCRX	Option Ex	15,000	1.61	24,150
2014-08-08	PCRX	Sale	15,000	99.53	1,492,875
2014-05-08	PCRX	Option Ex	15,000	1.61	24,150
2014-05-08	PCRX	Sale	15,000	75.11	1,126,605
2013-12-30	PCRX	Option Ex	10,000	1.61	16,100
2013-12-30	PCRX	Sale	10,000	55.55	555,500
2013-09-30	PCRX	Option Ex	10,000	1.61	16,100
2013-09-30	PCRX	Sale	10,000	46.74	467,400
2013-06-28	PCRX	Option Ex	10,000	1.61	16,100
2013-06-28	PCRX	Sale	10,000	28.05	280,460
2013-03-28	PCRX	Option Ex	10,000	1.61	16,100
2013-03-28	PCRX	Sale	10,000	28.49	284,900
2011-02-15	PCRX	Buy	5,000	7.04	35,200

Table 3. Insider trading of Aquestive Therapeutics, Inc. (AQST) by Scibetta James S

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2019-08-19	AQST	Buy	10,761	3.77	40,547
2019-08-20	AQST	Buy	11,310	3.80	43,000
2019-08-21	AQST	Buy	900	3.81	3,429

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Scibetta James S (Chief Financial Officer of Aquestive Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month